Antibody Directed Enzyme Prodrug Therapy (ADEPT) and Related Approaches for Anticancer Therapy

Author(s): M. Jung

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 1 , Issue 4 , 2001

Become EABM
Become Reviewer
Call for Editor


In antibody directed enzyme prodrug therapy (ADEPT) an antibody bound enzyme is targeted to tumor cells. This allows for selective activation of a nontoxic prodrug to a cytotoxic agent at the tumor site for cancer therapy. Site-selective prodrug activation results in reduced side effects in remote tissue. This article reviews ADEPT with emphasis on the chemical viewpoint and recent developments.

Keywords: Antibody Directed Enzyme Prodrug Therapy, ADEPT, Anticancer Therapy, Alkaline Phosphatase, Amino Peptidases, Aryl Sulfatase, Carboxylesterase, Carboxypeptidase A, Carboxypeptidase G2 (CpG2), Cytosine Deaminase

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2001
Page: [399 - 407]
Pages: 9
DOI: 10.2174/1389557013406747
Price: $65

Article Metrics

PDF: 11